FTC Six-Month Accomplishments
Date
Federal Trade Commission Acting Chairman Maureen K. Ohlhausen released a summary of the agency’s major accomplishments since President Trump named her to the position in January. “I have pursued my...
Displaying 1141 - 1160 of 2209
FTC Requires Baxter International and Claris Lifesciences to Divest 2 Types of Pharmaceutical Products as Condition of Baxter Acquiring Injectable Drugs Business from Claris
Date
Baxter International Inc. and Claris Lifesciences Limited have agreed to divest two types of pharmaceutical products to settle Federal Trade Commission charges that Baxter’s proposed $625 million...
FTC Acting Chairman Ohlhausen Selects D. Bruce Hoffman as Acting Director of the Agency’s Bureau of Competition
Date
Federal Trade Commission Acting Chairman Maureen K. Ohlhausen announced today that she has selected D. Bruce Hoffman, a partner at the law firm of Shearman & Sterling LLP, to be the Acting Director of...
FTC Staff Provides Additional Comment and Testimony in Tennessee Opposing Mountain States’ and Wellmont’s Certificate of Public Advantage Application
Date
Federal Trade Commission staff submitted an additional public comment to the Tennessee Department of Health that opposes issuing a certificate of public advantage (COPA) to Mountain States Health...
Acting FTC Chairman Ohlhausen Appoints Neil Chilson as Acting Chief Technologist
Date
Acting Federal Trade Commission Chairman Maureen K. Ohlhausen has appointed Neil Alan Chilson as the agency’s acting Chief Technologist. Chilson will be primarily responsible for advising Chairman...
Acting FTC Chairman Ohlhausen Announces Departure of Economics Bureau Director Ginger Zhe Jin, Appointment of Michael G. Vita as Acting Bureau Director
Date
Acting Federal Trade Commission Chairman Maureen K. Ohlhausen announced that FTC Bureau of Economics Director Ginger Zhe Jin is departing the agency to return to the University of Maryland and has...
FTC Staff Offers Comment on FCC’s Network Neutrality Proceeding
Date
The staff of the Federal Trade Commission has submitted comments to the Federal Communications Commission (FCC) supporting that agency’s proposal to restore FTC jurisdiction related to broadband...
FTC Approves Sublicense for Synacthen Depot Submitted by Mallinckrodt ARD Inc.
Date
The Federal Trade Commission has approved a sublicense submitted by Mallinckrodt ARD Inc. granting West Therapeutic Development, LLC certain rights to develop and market the specialty drug Synacthen...
FTC Approves Amendments to Divestiture Order in LafargeHolcim Ltd. Merger
Date
Following a public comment period, the Federal Trade Commission has approved an application from LaFargeHolcim, Ltd to amend several agreements that were part of a 2015 FTC order settling charges that...
Statement from FTC’s Acting Bureau of Competition Director Markus H. Meier on Decision by DraftKings and FanDuel to Abandon Their Proposed Merger
Date
“The parties’ decision to abandon this transaction is a clear win for American consumers,” said Markus H. Meier, Acting Director of the Bureau of Competition. “For years, the vigorous competition...
FTC Announces Agenda for First Economic Liberty Public Roundtable
Date
The FTC’s Economic Liberty Task Force has announced the agenda for its first Roundtable, Streamlining Licensing Across State Lines: Initiatives to Enhance Occupational License Portability. The July 27...
Federal Trade Commission Approves Appointment of Monitor in Pay-for-Delay Case against Endo Pharmaceuticals Inc.
Date
The Federal Trade Commission has approved the appointment of Quantic Regulatory Services, LLC as monitor in its case alleging that Endo Pharmaceuticals Inc. violated antitrust laws by using pay-for...
FTC Office and Bureau Directors Comment on State Legislative Proposal Affecting Compensation for North Carolina Real Estate Appraisers
Date
In response to a request from North Carolina Assistant Attorney General Roberta A. Ouellette, the directors of the Federal Trade Commission’s Office of Policy Planning, Bureau of Competition and...
FTC Acting Chairman Ohlhausen Announces Departure of Tad Lipsky and Appointment of Markus Meier as Acting Director of Competition Bureau
Date
Federal Trade Commission Acting Chairman Maureen K. Ohlhausen announced today that Abbott (Tad) Lipsky, Acting Director of the FTC’s Bureau of Competition, retired effective July 3, 2017. Lipsky was...
FTC Accepts Proposed Consent Order in Broadcom Limited’s $5.9 Billion Acquisition of Brocade Communications Systems, Inc.
Date
Semiconductor manufacturer Broadcom Limited has agreed to establish a firewall to remedy the FTC’s concerns that its proposed $5.9 billion acquisition of Brocade Communications Systems, Inc. is...
Humana, Inc.
Type of Action
Process Enforcement
Last Updated
FTC Matter/File Number
161-0026
Case Status
Closed
FTC Approves Final Order Preserving Competition in U.S. Market for Industrial Switchboxes
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Emerson Electric Co.’s acquisition of Pentair plc would be anticompetitive. First...
FTC and DOJ Approve Procedural Changes to HSR Form
Date
The Federal Trade Commission, with the concurrence of the Antitrust Division of the U.S. Department of Justice, has approved changes to the form that companies use to report a proposed merger...
Statement of the Acting Director of FTC’s Bureau of Competition Regarding the Walgreens/Rite Aid Transaction
Date
The Acting Director of the Federal Trade Commission’s Bureau of Competition, Tad Lipsky, issued the following statement on this morning’s announcement regarding Walgreens Boots Alliance, Inc.’s...
FTC Requests Public Comment on Application from Grifols, S.A. to Amend Contract Manufacturing Agreement that was part of 2011 Divestiture Ordered by the Agency
Date
The Federal Trade Commission is currently accepting public comments on an application by Grifols, S.A., a manufacturer of plasma-derived drugs, to amend the terms of a manufacturing agreement that was...
Displaying 1141 - 1160 of 2209